Research graph
References from Goal Attainment and Outcome Evaluation for Upper and Lower Limb Spasticity: A Real-Life Cohort Analysis in a Community-Based Outreach Service. Local targets link to admitted publications; unresolved targets remain external evidence.
Unresolved reference
External reference
Botulinum neurotoxin versus tizanidine in upper limb spasticity: A placebo-controlled study
10.1136/jnnp.2008.159657 · 2009 · External reference
Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: A double-blind randomised controlled trial
10.1016/s1474-4422(15)00216-1 · 2015 · External reference
Unresolved reference
External reference
Long-term treatment of spasticity with botulinum toxin type A: An analysis of 1221 treatments in 137 patients
10.1179/016164109x12478302362734 · 2010 · External reference
Effects of repeated abobotulinumtoxinA injections in upper limb spasticity
10.1002/mus.25721 · 2018 · External reference
When can maximal efficacy occur with repeat botulinum toxin injection in upper limb spastic paresis?
10.1093/braincomms/fcaa201 · 2021 · External reference
Individualized OnabotulinumtoxinA Treatment for Upper Limb Spasticity Resulted in High. Clinician- and Patient-Reported Satisfaction: Long-Term. Observational Results from the ASPIRE Study
2020 · External reference
Functional goal achievement in post-stroke spasticity patients: The BOTOX® Economic Spasticity Trial (BEST)
10.2340/16501977-1817 · 2014 · External reference
An International, Multicenter, Observational, Longitudinal Study to Assess the Effectiveness of AbobotulinumtoxinA Injections for Adult Lower Limb Spasticity: The AboLiSH Study
10.1212/wnl.94.15_supplement.560 · 2020 · External reference
10.3390/toxins13050303
10.3390/toxins13050303 · External reference
Accuracy of botulinum toxin type a injection into the forearm muscles of chronic stroke patients with spastic flexed wrist and clenched fist: Manual needle placement evaluated using ultrasonography
10.2340/16501977-1871 · 2014 · External reference
Adjunctive treatment and BoNT-A for post-stroke spasticity: Are we really focusing on the patient-centered goals?
10.3389/fneur.2023.1134691 · 2023 · External reference
10.3390/toxins13040236
10.3390/toxins13040236 · External reference
Adjunct therapies after botulinum toxin injections in spastic adults: Systematic review and SOFMER recommendations
10.1016/j.rehab.2021.101544 · 2022 · External reference
Systematic review of adjunct therapies to improve outcomes following botulinum toxin injection for treatment of limb spasticity
10.1177/0269215515593783 · 2016 · External reference
Goal attainment scaling: A general method of evaluating comprehensive mental health programmes
10.1007/bf01530764 · 1968 · External reference
Writing SMART rehabilitation goals and achieving goal attainment scaling: A practical guide
10.1177/0269215508101741 · 2009 · External reference
Goal attainment scaling (GAS) in rehabilitation: A practical guide
10.1177/0269215508101742 · 2009 · External reference
Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: A secondary analysis from a double-blind placebo-controlled randomized clinical trial
10.2340/16501977-0474 · 2010 · External reference
Goal attainment for spasticity management using botulinum toxin
10.1002/pri.36 · 2006 · External reference
Botulinum treatment of spasticity: Why is it difficult to show a functional benefit?
10.1097/00019052-200112000-00015 · 2001 · External reference
Common goal areas in the treatment of upper limb spasticity: A multicentre analysis
10.1177/0269215515593391 · 2016 · External reference
Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: Rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III)
10.1136/bmjopen-2016-011157 · 2016 · External reference
Categorisation of goals set using Goal Attainment Scaling for treatment of leg spasticity: A multicentre analysis
10.1080/09638288.2018.1451927 · 2019 · External reference
Conceptualisation and development of the arm activity measure (ArmA) for assessment of activity in the hemiparetic arm
10.3109/09638288.2012.743602 · 2013 · External reference
Conceptualisation and development of the Leg Activity Measure (LegA) for patient and carer reported assessment of activity (function) in the paretic leg in people with acquired brain injury
10.1002/pri.1660 · 2017 · External reference
Initial psychometric evaluation of the Arm Activity Measure (ArmA): A measure of activity in the hemiparetic arm
10.1177/0269215512474942 · 2013 · External reference
Psychometric evaluation of the leg activity measure (LegA) for outcome measurement in people with brain injury and spasticity
10.1080/09638288.2019.1643933 · 2021 · External reference
ULIS (Upper Limb International Spasticity), a 10-year Odyssey: An international, multicentric, longitudinal cohort of person-centered spasticity management in real-life practice
10.4103/jisprm.jisprm_47_19 · 2019 · External reference
Longitudinal goal attainment with repeat injections of abobotulinumtoxinA in adults with lower limb spasticity: Results from a prospective observational study
10.1016/j.apmr.2024.10.017 · 2025 · External reference
Real-life outcomes in spasticity management: Features affecting goal achievement
10.1136/bmjno-2019-000015 · 2020 · External reference
The efficacy of Botulinum Toxin A on improving ease of care in the upper and lower limbs: A systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach
10.1177/0269215514555036 · 2014 · External reference
Facilitators and barriers to patient-centred goal-setting in rehabilitation: A scoping review
10.1177/02692155221121006 · 2022 · External reference
Worldwide Survey of Clinician Practice on use of Adjunctive Therapies Following Botulinum Toxin Injection for Spasticity
10.2340/jrm.v54.334 · 2022 · External reference
Statement of the Rehabilitation Medicine Society of Australia and New Zealand for the therapeutic use of botulinum toxin A in spasticity management
10.1111/imj.16300 · 2024 · External reference
Post-stroke spasticity: Follow-up and functional implications of chronic long-term treatment with botulinum toxin
10.23736/s1973-9087.24.08429-6 · 2024 · External reference
10.3390/toxins17110558
10.3390/toxins17110558 · External reference
Prevalence of unmet needs for spasticity management in care home residents in the East Midlands, United Kingdom: A cross-sectional observational study
10.1177/0269215519859621 · 2019 · External reference
Ultrasound image guided injection of botulinum toxin for the management of spasticity: A Delphi study to develop recommendations for a scope of practice, competency, and a governance framework
2023 · External reference
Role extension in advanced ultrasound practice: A framework approach and case study
10.1177/1742271x221102577 · 2023 · External reference
Point of care ultrasound in pelvic health: Scope of practice, education and governance for physiotherapists
10.1007/s00192-022-05200-x · 2022 · External reference
An initial framework for use of ultrasound by speech and language therapists in the UK: Scope of practice, education and governance
10.1177/1742271x221122562 · 2023 · External reference
A proposed framework for point of care lung ultrasound by respiratory physiotherapists: Scope of practice, education, and governance
10.1186/s13089-022-00266-6 · 2022 · External reference
10.3390/toxins17030107
10.3390/toxins17030107 · External reference
10.3390/toxins16020098
10.3390/toxins16020098 · External reference
A Practical Guide to Optimizing the Benefits of Post-Stroke Spasticity Interventions With Botulinum Toxin A: An International Group Consensus
2020 · External reference
European consensus table on the use of botulinum toxin type A in adult spasticity
10.2340/16501977-0303 · 2009 · External reference
OnabotulinumtoxinA for lower limb spasticity: Guidance from a Delphi panel approach
10.1016/j.pmrj.2017.02.014 · 2017 · External reference
Practice guideline update summary: Botulinum neurotoxin for the treatment of blepharospasm, cervical dystonia, adult spasticity and headache: Report of the Guideline Development Subcommittee of the American Academy of Neurology
2016 · External reference
Effects of repeated abobotulinumtoxinA injections in upper limb spasticity
10.1002/mus.25721 · ExternalCitation · doi-reference
Conceptualisation and development of the Leg Activity Measure (LegA) for patient and carer reported assessment of activity (function) in the paretic leg in people with acquired brain injury
10.1002/pri.1660 · ExternalCitation · doi-reference
Goal attainment for spasticity management using botulinum toxin
10.1002/pri.36 · ExternalCitation · doi-reference
Goal attainment scaling: A general method of evaluating comprehensive mental health programmes
10.1007/bf01530764 · ExternalCitation · doi-reference
Point of care ultrasound in pelvic health: Scope of practice, education and governance for physiotherapists
10.1007/s00192-022-05200-x · ExternalCitation · doi-reference
Longitudinal goal attainment with repeat injections of abobotulinumtoxinA in adults with lower limb spasticity: Results from a prospective observational study
10.1016/j.apmr.2024.10.017 · ExternalCitation · doi-reference
OnabotulinumtoxinA for lower limb spasticity: Guidance from a Delphi panel approach
10.1016/j.pmrj.2017.02.014 · ExternalCitation · doi-reference
Adjunct therapies after botulinum toxin injections in spastic adults: Systematic review and SOFMER recommendations
10.1016/j.rehab.2021.101544 · ExternalCitation · doi-reference
Safety and efficacy of abobotulinumtoxinA for hemiparesis in adults with upper limb spasticity after stroke or traumatic brain injury: A double-blind randomised controlled trial
10.1016/s1474-4422(15)00216-1 · ExternalCitation · doi-reference
Categorisation of goals set using Goal Attainment Scaling for treatment of leg spasticity: A multicentre analysis
10.1080/09638288.2018.1451927 · ExternalCitation · doi-reference
Psychometric evaluation of the leg activity measure (LegA) for outcome measurement in people with brain injury and spasticity
10.1080/09638288.2019.1643933 · ExternalCitation · doi-reference
When can maximal efficacy occur with repeat botulinum toxin injection in upper limb spastic paresis?
10.1093/braincomms/fcaa201 · ExternalCitation · doi-reference
Botulinum treatment of spasticity: Why is it difficult to show a functional benefit?
10.1097/00019052-200112000-00015 · ExternalCitation · doi-reference
Statement of the Rehabilitation Medicine Society of Australia and New Zealand for the therapeutic use of botulinum toxin A in spasticity management
10.1111/imj.16300 · ExternalCitation · doi-reference
Real-life outcomes in spasticity management: Features affecting goal achievement
10.1136/bmjno-2019-000015 · ExternalCitation · doi-reference
Impact of integrated upper limb spasticity management including botulinum toxin A on patient-centred goal attainment: Rationale and protocol for an international prospective, longitudinal cohort study (ULIS-III)
10.1136/bmjopen-2016-011157 · ExternalCitation · doi-reference
Botulinum neurotoxin versus tizanidine in upper limb spasticity: A placebo-controlled study
10.1136/jnnp.2008.159657 · ExternalCitation · doi-reference
Writing SMART rehabilitation goals and achieving goal attainment scaling: A practical guide
10.1177/0269215508101741 · ExternalCitation · doi-reference
Goal attainment scaling (GAS) in rehabilitation: A practical guide
10.1177/0269215508101742 · ExternalCitation · doi-reference
Initial psychometric evaluation of the Arm Activity Measure (ArmA): A measure of activity in the hemiparetic arm
10.1177/0269215512474942 · ExternalCitation · doi-reference
The efficacy of Botulinum Toxin A on improving ease of care in the upper and lower limbs: A systematic review and meta-analysis using the Grades of Recommendation, Assessment, Development and Evaluation approach
10.1177/0269215514555036 · ExternalCitation · doi-reference
Common goal areas in the treatment of upper limb spasticity: A multicentre analysis
10.1177/0269215515593391 · ExternalCitation · doi-reference
Systematic review of adjunct therapies to improve outcomes following botulinum toxin injection for treatment of limb spasticity
10.1177/0269215515593783 · ExternalCitation · doi-reference
Prevalence of unmet needs for spasticity management in care home residents in the East Midlands, United Kingdom: A cross-sectional observational study
10.1177/0269215519859621 · ExternalCitation · doi-reference
Facilitators and barriers to patient-centred goal-setting in rehabilitation: A scoping review
10.1177/02692155221121006 · ExternalCitation · doi-reference
Role extension in advanced ultrasound practice: A framework approach and case study
10.1177/1742271x221102577 · ExternalCitation · doi-reference
An initial framework for use of ultrasound by speech and language therapists in the UK: Scope of practice, education and governance
10.1177/1742271x221122562 · ExternalCitation · doi-reference
Long-term treatment of spasticity with botulinum toxin type A: An analysis of 1221 treatments in 137 patients
10.1179/016164109x12478302362734 · ExternalCitation · doi-reference
A proposed framework for point of care lung ultrasound by respiratory physiotherapists: Scope of practice, education, and governance
10.1186/s13089-022-00266-6 · ExternalCitation · doi-reference
An International, Multicenter, Observational, Longitudinal Study to Assess the Effectiveness of AbobotulinumtoxinA Injections for Adult Lower Limb Spasticity: The AboLiSH Study
10.1212/wnl.94.15_supplement.560 · ExternalCitation · doi-reference
European consensus table on the use of botulinum toxin type A in adult spasticity
10.2340/16501977-0303 · ExternalCitation · doi-reference
Goal attainment scaling in the evaluation of treatment of upper limb spasticity with botulinum toxin: A secondary analysis from a double-blind placebo-controlled randomized clinical trial
10.2340/16501977-0474 · ExternalCitation · doi-reference
Functional goal achievement in post-stroke spasticity patients: The BOTOX® Economic Spasticity Trial (BEST)
10.2340/16501977-1817 · ExternalCitation · doi-reference
Accuracy of botulinum toxin type a injection into the forearm muscles of chronic stroke patients with spastic flexed wrist and clenched fist: Manual needle placement evaluated using ultrasonography
10.2340/16501977-1871 · ExternalCitation · doi-reference
Worldwide Survey of Clinician Practice on use of Adjunctive Therapies Following Botulinum Toxin Injection for Spasticity
10.2340/jrm.v54.334 · ExternalCitation · doi-reference
Post-stroke spasticity: Follow-up and functional implications of chronic long-term treatment with botulinum toxin
10.23736/s1973-9087.24.08429-6 · ExternalCitation · doi-reference
Conceptualisation and development of the arm activity measure (ArmA) for assessment of activity in the hemiparetic arm
10.3109/09638288.2012.743602 · ExternalCitation · doi-reference
Adjunctive treatment and BoNT-A for post-stroke spasticity: Are we really focusing on the patient-centered goals?
10.3389/fneur.2023.1134691 · ExternalCitation · doi-reference
10.3390/toxins13040236
10.3390/toxins13040236 · ExternalCitation · doi-reference
10.3390/toxins13050303
10.3390/toxins13050303 · ExternalCitation · doi-reference
10.3390/toxins16020098
10.3390/toxins16020098 · ExternalCitation · doi-reference
10.3390/toxins17030107
10.3390/toxins17030107 · ExternalCitation · doi-reference
10.3390/toxins17110558
10.3390/toxins17110558 · ExternalCitation · doi-reference
ULIS (Upper Limb International Spasticity), a 10-year Odyssey: An international, multicentric, longitudinal cohort of person-centered spasticity management in real-life practice
10.4103/jisprm.jisprm_47_19 · ExternalCitation · doi-reference
